Exicure, Inc. Common Stock

XCURNASDAQUSD
2.42 USD
0.10 (4.17%)🟢PRE MARKET (AS OF 09:13 AM EDT)
🟢Market: OPEN

Exicure, Inc. Common Stock (XCUR) is currently trading at $2.42. Technical and fundamental signals converge bearishtechnicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, XCUR trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jun 25, 2026.

Open?$2.52
High?$2.77
Low?$2.42
Prev. Close?$2.52
Volume?13.2K
Avg. Volume?29.8K
VWAP?$2.58
Rel. Volume?0.44x
Bid / Ask
Bid?$2.15 × 100
Ask?$3.16 × 100
Spread?$1.01
Midpoint?$2.66
Valuation & Ratios
Market Cap?16.1M
Shares Out?6.4M
Float?4.3M
Float %?67.2%
P/E Ratio?N/A
P/B Ratio?7.66
EPS?-$1.54
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.
Employees
8
Market Cap
17.1M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2018-05-09
Address
2430 N. HALSTED ST.
CHICAGO, IL 60614
Phone: 847-673-1707
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Bearish(-1/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
80
Piotroski F-Score?0/9Weak
Altman Z-Score?-22.50Distress
Confidence?40%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.34%Low
Short Interest?14.8K
Days to Cover?1.0
Free Float4.3M
Avg Daily Volume20.4K
Settlement Date2026-06-15
Financial Health
Current Ratio?0.79Weak
Quick Ratio?0.79Weak
Cash Ratio?0.58Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A
P/B?
Peers
100
S&P
24
7.66FAIR
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-1.6CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-466.4%WEAK
ROA?
S&P
3
-76.7%WEAK
Cash Flow & Enterprise
FCF?$-8100000
Enterprise Value?$13.5M
Fundamentals ratios updated end of day